Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
about
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal womenSignificance of Ovarian Function Suppression in Endocrine Therapy for Breast Cancer in Pre-Menopausal WomenManaging breast cancer in younger women: challenges and solutionsChemotherapy in Premenopausal Breast Cancer PatientsAdjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineBody composition changes in females treated for breast cancer: a review of the evidenceChemotherapy- and irradiation-induced bone loss in adults with solid tumorsPremature menopause or early menopause: long-term health consequencesA pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancerIncidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.A multidimensional scale to measure the reproductive concerns of young adult female cancer survivors.Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12)Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivorsOvarian preservation by GnRH agonists during chemotherapy: a meta-analysis.Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors.Incidence of chemotherapy-induced amenorrhea after adjuvant chemotherapy with taxane and anthracyclines in young patients with breast cancerEndocrine Therapy - What Else?Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.Longitudinal assessment of bone loss from diagnostic computed tomography scans in gynecologic cancer patients treated with chemotherapy and radiationAssociation between self-reported questionnaire data on fertility and results of hormone analyses in women after childhood cancer: a cross-sectional study.The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.Is Chemoendocrine Treatment without Alternative?Breast cancer in young women: special considerations in multidisciplinary care.A review of breast cancer survivorship issues from survivors' perspectives.Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patientsTamoxifen and ovarian function.Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced AmenorrheaBreast cancer in young womenA comparison of disrupted sleep patterns in women with cancer-related fatigue and postmenopausal women without cancer.Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.Fertility preservation and breast cancer: a reviewEfficient differentiation of steroidogenic and germ-like cells from epigenetically-related iPSCs derived from ovarian granulosa cells.Orthotopic transplantation of cryopreserved mouse ovaries and gonadotrophin releasing hormone analogues in the restoration of function following chemotherapy-induced ovarian damage.Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trialsChemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone ProfilesUtility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis.Fertility preservation in reproductive-age women facing gonadotoxic treatments.SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study.
P2860
Q24240015-E4F03017-6649-4633-A0B7-D95DD5D75238Q26745464-80DA9DFC-018A-4633-BADA-90CC8A5E719DQ26771184-1BD35B7E-8E95-4360-AAD6-FD1E44B2AB32Q26774622-BE321C6C-1EA4-421F-AD4F-2EBA38E31506Q27002430-EFF627AB-6EF8-40A8-95FB-461C41112904Q27004662-34DE9B6E-AED5-4FBC-86F7-BB247E219141Q28084019-8E21705E-0D62-426A-A7E6-A4E2C96953E0Q28257628-8B332EA3-ABFA-4C29-8259-FAAC0CF10DADQ30435881-EE133993-7B7E-4904-8A4B-7E44A37AF3C0Q33320772-D87E81F2-1988-41E3-923A-FF4A23D73AE2Q33590794-836A4495-CD07-4242-A085-158750D964B0Q33601886-EAE34F83-6DE7-4310-999D-89A8A1E208E3Q33618145-B3D89BA8-2EFB-4F71-B1AD-CDAB6D554263Q33624886-F4693515-B055-418D-85B0-D0D5B1A9DCDAQ33805271-36A22263-CAE1-4BE0-A091-64C043500041Q33937239-A862F2FB-0D2C-48D1-95A6-C197FFD036ADQ34082383-E93FC801-452E-4407-A446-F8515C0D5319Q34096265-593E851E-DECE-4148-86D0-75820B92A905Q34109991-8D31B9EB-2870-46ED-9921-8A2073936230Q34163856-906B1551-EA31-4937-A70D-6D9A5E6E7646Q34260350-C95FE940-A716-4AC6-9896-A0FB6DFD0749Q34277890-58571DBA-51E3-4873-8F17-A83524354A2CQ34284263-36235D7F-8C2D-45E4-8333-73A43AF8139DQ34306522-FD688960-DCAF-4B27-BB47-66FCBB6C358AQ34340570-21F73DDD-565C-4319-928C-CB5617246932Q34550633-85A0A45C-1FC3-4F07-86BF-9F32C0EA2E44Q34805784-6635DA38-09D0-4914-9D18-46522EA5B3DDQ34877439-67DC35A3-C14E-4909-934E-5136A2B66B95Q34977189-21282A1B-4C20-49AF-B56E-573AD906BA1DQ34989073-5719B4C8-1813-4395-818B-B7E9982B0BECQ35050788-BB21FEEA-CD9B-4676-B9CE-02BE7EC43ADBQ35097386-0C079894-1C56-4D4A-BE02-C6E9720980F9Q35106163-3F69C095-383F-45B3-B424-7138F6BAAB95Q35159151-6AF6CFAD-80CB-4F8E-A474-8CC6A74EA6E2Q35220166-E4DF2C2C-3E6B-4E83-9662-D1BAA2DF5C58Q35740423-59D9210C-6BC2-428D-99A5-5E64DF5DFEFAQ35814842-27A37BDE-6338-4DD4-A7FD-9E56E0191161Q35856600-0409154D-371F-4B65-A6D2-DC7820537158Q35934317-30DA5F8E-AF61-4FB1-9C57-AF0448EE9034Q36032817-BA2674C9-C80E-4D4B-AF95-80A8F3219F75
P2860
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
@ast
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
@en
type
label
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
@ast
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
@en
prefLabel
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
@ast
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
@en
P356
P1476
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer
@en
P2093
Janice M Walshe
Neelima Denduluri
P304
P356
10.1200/JCO.2006.07.2793
P407
P577
2006-11-27T00:00:00Z